Neuland Laboratories Limited (NEULANDLAB.NS)
INR 11952.0
(-0.33%)
INR 11952.0
(-0.33%)
| Year | Inventory | Inventory Growth |
|---|---|---|
| 2023 | 3.5 Billion INR | 25.49% |
| 2022 | 2.79 Billion INR | 5.29% |
| 2021 | 2.65 Billion INR | 7.11% |
| 2020 | 2.47 Billion INR | 12.78% |
| 2019 | 2.19 Billion INR | 13.96% |
| 2018 | 1.92 Billion INR | 10.03% |
| 2017 | 1.75 Billion INR | 30.18% |
| 2016 | 1.34 Billion INR | 6.19% |
| 2015 | 1.26 Billion INR | 11.69% |
| 2014 | 1.13 Billion INR | 21.39% |
| 2013 | 934.17 Million INR | 1.35% |
| 2012 | 921.69 Million INR | -0.27% |
| 2011 | 924.18 Million INR | 15.64% |
| 2010 | 799.16 Million INR | 11.11% |
| 2009 | 719.27 Million INR | 2.07% |
| 2008 | 704.66 Million INR | 0.0% |
| Year | Inventory | Inventory Growth |
|---|---|---|
| 2024 Q1 | - INR | -100.0% |
| 2023 Q2 | 2.96 Billion INR | 0.0% |
| 2023 Q1 | - INR | -100.0% |
| 2023 FY | 3.5 Billion INR | 25.49% |
| 2023 Q4 | 3.5 Billion INR | 0.0% |
| 2023 Q3 | - INR | -100.0% |
| 2022 Q4 | 2.79 Billion INR | 0.0% |
| 2022 FY | 2.79 Billion INR | 5.29% |
| 2022 Q1 | - INR | -100.0% |
| 2022 Q2 | 2.88 Billion INR | 0.0% |
| 2022 Q3 | - INR | -100.0% |
| 2021 Q1 | - INR | -100.0% |
| 2021 FY | 2.65 Billion INR | 7.11% |
| 2021 Q4 | 2.65 Billion INR | 0.0% |
| 2021 Q3 | - INR | -100.0% |
| 2021 Q2 | 2.89 Billion INR | 0.0% |
| 2020 Q2 | 2.35 Billion INR | 0.0% |
| 2020 Q4 | 2.47 Billion INR | 0.0% |
| 2020 Q3 | - INR | -100.0% |
| 2020 FY | 2.47 Billion INR | 12.78% |
| 2020 Q1 | - INR | -100.0% |
| 2019 FY | 2.19 Billion INR | 13.96% |
| 2019 Q2 | 2.14 Billion INR | 0.0% |
| 2019 Q1 | - INR | -100.0% |
| 2019 Q3 | - INR | -100.0% |
| 2019 Q4 | 2.19 Billion INR | 0.0% |
| 2018 Q4 | 1.92 Billion INR | 0.0% |
| 2018 FY | 1.92 Billion INR | 10.03% |
| 2018 Q1 | - INR | 0.0% |
| 2017 FY | 1.75 Billion INR | 30.18% |
| 2016 FY | 1.34 Billion INR | 6.19% |
| 2016 Q3 | 1.34 Billion INR | 11.33% |
| 2016 Q2 | 1.2 Billion INR | 0.0% |
| 2016 Q1 | - INR | 0.0% |
| 2016 Q4 | 1.35 Billion INR | 0.46% |
| 2015 FY | 1.26 Billion INR | 11.69% |
| 2014 FY | 1.13 Billion INR | 21.39% |
| 2013 FY | 934.17 Million INR | 1.35% |
| 2012 FY | 921.69 Million INR | -0.27% |
| 2011 FY | 924.18 Million INR | 15.64% |
| 2010 FY | 799.16 Million INR | 11.11% |
| 2009 FY | 719.27 Million INR | 2.07% |
| 2008 FY | 704.66 Million INR | 0.0% |
| Name | Inventory | Inventory Difference |
|---|---|---|
| Amrutanjan Health Care Limited | 289.04 Million INR | -1112.335% |
| Biofil Chemicals and Pharmaceuticals Limited | 25.49 Million INR | -13643.652% |
| Caplin Point Laboratories Limited | 3.63 Billion INR | 3.476% |
| FDC Limited | 3.88 Billion INR | 9.891% |
| Gufic Biosciences Limited | 2 Billion INR | -74.79% |
| Hikal Limited | 3.03 Billion INR | -15.377% |
| Ind-Swift Laboratories Limited | 104.57 Million INR | -3250.851% |
| IOL Chemicals and Pharmaceuticals Limited | 4.24 Billion INR | 17.517% |
| Kilitch Drugs (India) Limited | 39.88 Million INR | -8686.908% |
| Medico Remedies Limited | 163.37 Million INR | -2044.932% |
| Nectar Lifesciences Limited | 7.09 Billion INR | 50.586% |
| Par Drugs and Chemicals Limited | 41.77 Million INR | -8289.32% |
| RPG Life Sciences Limited | 1.01 Billion INR | -246.952% |
| Sequent Scientific Limited | 3.46 Billion INR | -1.21% |
| Shilpa Medicare Limited | 3.44 Billion INR | -1.593% |
| Sigachi Industries Limited | 707.2 Million INR | -395.501% |
| Themis Medicare Limited | 705.74 Million INR | -396.529% |
| Unichem Laboratories Limited | 7.04 Billion INR | 50.272% |
| Venus Remedies Limited | 1.21 Billion INR | -187.963% |
| Wanbury Limited | 360.23 Million INR | -872.767% |
| ZIM Laboratories Limited | 812.62 Million INR | -331.22% |
| Lupin Limited | 49.53 Billion INR | 92.926% |
| Innova Captab Limited | 1.44 Billion INR | -143.322% |
| Ind-Swift Limited | 640.91 Million INR | -446.753% |
| Bajaj HealthCare Limited | 1.44 Billion INR | -143.284% |
| Aurobindo Pharma Limited | 98.08 Billion INR | 96.427% |
| Solara Active Pharma Sciences Limited | 3.59 Billion INR | 2.579% |
| AstraZeneca Pharma India Limited | 2.27 Billion INR | -53.773% |
| Mangalam Drugs & Organics Limited | 1.23 Billion INR | -183.422% |
| Morepen Laboratories Limited | 2.48 Billion INR | -40.961% |
| Laurus Labs Limited | 18.45 Billion INR | 81.011% |
| Aarti Drugs Limited | 4.85 Billion INR | 27.88% |
| Glenmark Life Sciences Limited | 6.66 Billion INR | 47.431% |
| Alembic Limited | 113.4 Million INR | -2990.14% |
| Alembic Pharmaceuticals Limited | 16.43 Billion INR | 78.679% |
| Glenmark Pharmaceuticals Limited | 25.13 Billion INR | 86.056% |
| Vaishali Pharma Limited | 3.79 Million INR | -92189.149% |
| Aarti Pharmalabs Limited | 6.42 Billion INR | 45.49% |
| Jagsonpal Pharmaceuticals Limited | 149.97 Million INR | -2236.613% |
| Jubilant Pharmova Limited | 12.89 Billion INR | 72.827% |
| Eris Lifesciences Limited | 1.89 Billion INR | -85.377% |
| Windlas Biotech Limited | 621.89 Million INR | -463.479% |
| Sun Pharmaceutical Industries Limited | 98.68 Billion INR | 96.449% |
| Lincoln Pharmaceuticals Limited | 771.68 Million INR | -354.102% |
| Orchid Pharma Limited | 2.64 Billion INR | -32.622% |
| Albert David Limited | 436.12 Million INR | -703.497% |
| Hester Biosciences Limited | 755.81 Million INR | -363.638% |
| Sakar Healthcare Limited | 277.32 Million INR | -1163.588% |
| Suven Pharmaceuticals Limited | 2.31 Billion INR | -51.569% |
| Procter & Gamble Health Limited | 1.09 Billion INR | -221.164% |
| Divi's Laboratories Limited | 31.84 Billion INR | 88.994% |
| Mankind Pharma Limited | 15.53 Billion INR | 77.443% |
| J. B. Chemicals & Pharmaceuticals Limited | 5.02 Billion INR | 30.266% |
| Zydus Lifesciences Limited | 34.41 Billion INR | 89.819% |
| Wockhardt Limited | 6.4 Billion INR | 45.247% |
| Bal Pharma Limited | 878.11 Million INR | -299.062% |
| Dr. Reddy's Laboratories Limited | 63.55 Billion INR | 94.486% |
| Bliss GVS Pharma Limited | 1.18 Billion INR | -195.846% |
| Alkem Laboratories Limited | 26.61 Billion INR | 86.832% |
| Valiant Laboratories Limited | 100.15 Million INR | -3398.831% |
| Ajanta Pharma Limited | 8.28 Billion INR | 57.697% |
| Bafna Pharmaceuticals Limited | 296.41 Million INR | -1082.188% |
| Aarey Drugs & Pharmaceuticals Limited | 346.75 Million INR | -910.568% |
| Granules India Limited | 13 Billion INR | 73.056% |
| Medicamen Biotech Limited | 593.75 Million INR | -490.182% |
| Ipca Laboratories Limited | 24.71 Billion INR | 85.82% |
| Brooks Laboratories Limited | 96.1 Million INR | -3546.126% |
| Syncom Formulations (India) Limited | 210.81 Million INR | -1562.225% |
| Piramal Enterprises Limited | - INR | -Infinity% |
| Torrent Pharmaceuticals Limited | 22.79 Billion INR | 84.624% |
| NATCO Pharma Limited | 7 Billion INR | 49.975% |
| Suven Life Sciences Limited | 7.08 Million INR | -49359.689% |
| Krebs Biochemicals & Industries Limited | 97.96 Million INR | -3477.048% |
| Strides Pharma Science Limited | 11.26 Billion INR | 68.886% |
| Indoco Remedies Limited | 3.53 Billion INR | 0.747% |
| Alpa Laboratories Limited | 136.65 Million INR | -2464.319% |
| Lasa Supergenerics Limited | 190.43 Million INR | -1740.123% |
| Sun Pharma Advanced Research Company Limited | 14.79 Million INR | -23589.961% |